Bifidobacterium and Lacticaseibacillus

N/A

Report date: 2025/02/10 20:00:43

Base Information

Drug NameBifidobacterium and Lacticaseibacillus
Drug Alias NameMulti-strain probiotics
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsUpdating
Therapy Area/IndicationsEnterocolitis, Necrotizing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Calgary
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Calgary
Inactive CompaniesN/A
Active IndicationsEnterocolitis, Necrotizing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A